Controversies have emerged as to whether ERG activates or attenuates the AR signaling, leading to the hypothesis that ERG can promote the oncogenic functions of AR (e.g., promoting survival of the prostate cells) while inhibiting the tumor-suppressing ones (e.g., differentiation) [107]. The gene discussed is AR; the disease is neoplasm.